Kamagra Chewable

Basic Kamagra Chewable information

• INN (international nonproprietary name): sildenafil — a selective inhibitor of phosphodiesterase type 5 (PDE5).
• Brand names: Kamagra Chewable (not authorised in the UK).
• ATC code: G04BE03.
• Forms and dosages: Kamagra Chewable — 100 mg chewable tablet, typically supplied in blisters of 4 tablets with fruit flavours; licensed generic sildenafil tablets — 25 mg, 50 mg, 100 mg.
• Manufacturer: Ajanta Pharma.
• Registration status in the United Kingdom: Kamagra Chewable is not an MHRA-authorised product.
• OTC / Rx classification: Prescription-only (Rx); chewable sildenafil for ED is not available over the counter.

Legal status and availability in the UK

In our online pharmacy, Kamagra Chewable is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

Clinical effectiveness in the UK

Will sildenafil help me or my patient with erectile dysfunction?

Licensed sildenafil provides robust symptomatic improvement for many men with erectile dysfunction when prescribed after clinical assessment.

Patient‑reported outcomes often describe improved confidence and relationship satisfaction following an effective regimen.

Durability of benefit varies by aetiology, with men who have diabetes or significant cardiovascular disease sometimes reporting less marked responses.

NHS prescribing pathways use licensed sildenafil (brand or generic) after assessment via GP, sexual health clinics or private prescribers.

Kamagra Chewable products are typically absent from regulated NHS formularies.

Common mild adverse events include headache, flushing and nasal congestion.

Serious events are rare but require urgent care when they occur.

Clinical records and GP electronic health records should document assessment, treatment choice and any adverse events.

Indications and expanded uses

What is sildenafil licensed for and when is off‑label use considered?

Licensed indication for sildenafil is erectile dysfunction in adult men.

Sildenafil is also licensed, as separate products, for pulmonary arterial hypertension; enquiries about other uses such as infertility or prostatitis prevention are off‑label and need specialist oversight.

MHRA and NHS formularies limit prescribing to authorised indications and formulations.

Kamagra Chewable is not authorised by the MHRA.

Off‑label prescribing in NHS practice can be appropriate for complex cases but requires documented benefit–risk discussion and informed consent.

Simple definitions for clinicians:

• Licensed use — erectile dysfunction in adult men.
• Common off‑label enquiries — fertility support, prostatitis-related questions.
• Unrecommended uses — unsanctioned self‑medication without clinical review.

When used off‑label, clinicians should document rationale, monitoring plans and report adverse events to the Yellow Card scheme.

Composition and brand landscape

What is in these tablets and who makes them?

The active ingredient is sildenafil (INN), a selective PDE5 inhibitor.

Kamagra Chewable is typically a 100 mg fruit‑flavoured chewable tablet manufactured by Ajanta Pharma and supplied in blisters of four tablets.

Flavours often listed include banana, pineapple, orange and strawberry.

Licensed UK sildenafil products, such as Viagra and generic sildenafil tablets, are available by prescription.

Chewable sildenafil presentations generally lack MHRA approval.

Other PDE5 inhibitors available in NHS practice include tadalafil, vardenafil and avanafil as alternatives where clinically indicated.

Contraindications and special precautions

Who should not take sildenafil?

Absolute contraindications include:

• Concurrent nitrate therapy.
• Recent cardiovascular events such as myocardial infarction or stroke within six months.
• Unstable angina or severe hypotension.
• Known hypersensitivity to sildenafil or tablet excipients.
• Congenital degenerative retinal disorders such as retinitis pigmentosa.

Relative cautions include renal or hepatic impairment, severe cardiac disease, major arrhythmias, conditions predisposing to priapism and co‑prescription with potent CYP3A4 inhibitors.

Life‑threatening interaction

Do not combine sildenafil with any nitrate‑containing medication — this can cause severe hypotension.

Practical UK advice for pharmacists:

• Screen for nitrates and recent cardiac history using the NHS Summary Care Record.
• Ask about prescription medicines that may interact, and record advice in the patient notes.

Advise patients to stop and seek urgent care if they develop symptoms such as chest pain, severe dizziness or sudden visual loss.

Dosage guidelines

How should chewable sildenafil be dosed in practice?

Standard on‑demand dosing per product information is one 100 mg chewable tablet taken about 30–60 minutes before sexual activity with a maximum of one tablet in 24 hours.

NHS practice commonly starts many patients at 50 mg and titrates according to response and tolerability.

Elderly patients and those with hepatic or renal impairment often start at lower doses such as 25–50 mg with careful monitoring.

Chewable tablets are sometimes claimed to have faster onset, but robust comparative randomised controlled trial evidence is limited.

Missed doses are not applicable for on‑demand use.

Overdose symptoms may include persistent erection, visual changes, severe headache or flushing; seek immediate medical attention.

Interactions overview

Which medicines and substances interact with sildenafil?

Absolute contraindication exists with nitrates because of risk of severe hypotension.

Strong CYP3A4 inhibitors such as ritonavir and ketoconazole can significantly increase sildenafil concentrations and require dose adjustment or avoidance.

Alpha‑blockers combined with sildenafil may cause symptomatic hypotension, so concurrent use needs careful review and possible dose spacing.

High‑fat meals can delay absorption and alcohol may potentiate vasodilatory effects and dizziness.

Counsel patients to review prescriptions via the NHS Summary Care Record and avoid buying unregulated online products with unknown excipients or dosing.

Comparable medicines and preferences

How do alternatives stack up against sildenafil?

NHS‑preferred alternatives include sildenafil (tablets/film), tadalafil for longer duration, vardenafil and avanafil for rapid onset or differing tolerability.

Choice depends on onset time, duration, interaction profile and licence status.

For men who prioritise chewable formats, discuss the lack of authorised chewable sildenafil in UK formularies and balance patient priorities with safety and licensing.

A short decision checklist for prescribers includes clinical suitability, comorbidities, concurrent medications, patient preference and licensed availability.

Frequently asked questions

Is Kamagra Chewable legal in the UK?

Kamagra Chewable is not MHRA authorised and is not supplied through standard UK pharmacy routes.

Are chewable tablets faster than standard tablets?

Chewable formulations claim quicker onset, but comparative clinical evidence is limited and onset is commonly still 30–60 minutes.

What if I experience a persistent erection?

Priapism — an erection lasting more than four hours — is a medical emergency; seek A&E immediately.

Can I take sildenafil with nitrates or alpha‑blockers?

Do not take sildenafil with nitrates under any circumstances.

Exercise caution with alpha‑blockers and seek clinician review before combining medications.

Report adverse events via the MHRA Yellow Card scheme and use NHS advice lines for urgent clinical queries.

Guidelines for proper use

What should pharmacists cover during counselling?

Verify prescription and medication history via the NHS Summary Care Record.

Screen specifically for nitrates, recent cardiac events and key comorbidities.

Advise dosing: one 100 mg chewable about 30–60 minutes before activity and no more than one in 24 hours unless otherwise instructed.

Explain common side effects and when to seek urgent care, including sudden visual loss or priapism.

Encourage Yellow Card reporting for suspected adverse reactions and record counselling in patient notes.

For patients buying online, advise checking MHRA licences and avoiding unregulated imports; recommend GP review before use.

Pharmacist counselling checklist:

• Confirm current medications and nitrates.
• Assess cardiovascular risk and recent events.
• Agree dose and provide timing guidance.
• Document advice and report adverse events as needed.

Delivery across the United Kingdom